Aspartic acid

Generic Name: Aspartic acid

Brand Names: Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinisol 15, Olimel, Periolimel, Plenamine, Premasol, Primene, Prosol, Trophamine 10 %

Drug Type: Small Molecule

Chemical Formula: C_₄H_₇NO_₄

CAS Number: 56-84-8

Unique Ingredient Identifier: 30KYC7MIAI

Background: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.

Indication: There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.

Associated Therapies: Amino acid supplementation

Clinical Trials

the Effect of Use of Vit d and Probiotic as a Supplementaition in the Treatment of Bronchial Asthma in Patient Aged 6 to 50 Year and Its Effect in Decrasing Excerbation.

Completed

Conditions: Bronchial Asthma

Interventions: Drug: Vit D

First Posted Date: 2025-05-08

Last Posted Date: 2025-05-08

Lead Sponsor: Al-Azhar University

Target Recruit Count: 200

Registration Number: NCT06962761

Locations: 🇪🇬
ALAzhar university hospital assiut, Assiut, Egypt

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

Phase 2

Active, not recruiting

Conditions: Pneumococcal Disease, Invasive

Interventions: Biological: Formulation B
Biological: Formulation C
Biological: Formulation D
Biological: Prevnar20

First Posted Date: 2025-01-24

Last Posted Date: 2025-04-16

Lead Sponsor: Inventprise Inc.

Target Recruit Count: 421

Registration Number: NCT06790290

Locations: 🇵🇭
Health Index Multispecialty Clinic, Bacoor, Cavite, Philippines
🇵🇭
Grand Centennial Homes Clinic, Kawit, Cavite, Philippines
🇵🇭
University of the Philippines-National Health Institute_Doña Nena Health Center, Pasay, Metro Manila, Philippines

A Study to Learn How Different Tablets of the Study Medicine Mevrometostat Are Taken up Into the Blood in Healthy Adults

Phase 1

Withdrawn

Conditions: Healthy

Interventions: Drug: Treatment A
Drug: Treatment B
Drug: Treatment C
Drug: Treatment D

First Posted Date: 2024-10-28

Last Posted Date: 2025-04-24

Lead Sponsor: Pfizer

Target Recruit Count: 16

Registration Number: NCT06661694

Locations: 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium

A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants

Phase 1

Active, not recruiting

Conditions: Healthy

Interventions: Biological: Cohort A
Biological: Cohort B
Biological: Cohort C
Biological: Cohort D

First Posted Date: 2024-10-15

Last Posted Date: 2024-10-15

Lead Sponsor: Uniquity One (UNI)

Target Recruit Count: 48

Registration Number: NCT06640920

Locations: 🇺🇸
Research Site, Cincinnati, Ohio, United States

Effect of Vitamin D Supplementation on Mental Health: An Exploratory Study on A University Students Suffering From Vitamin D Deficiency

Phase 1

Not yet recruiting

Conditions: Psychiatric Disorder

Interventions: Drug: Vit D
Other: Placebo

First Posted Date: 2024-06-13

Last Posted Date: 2024-06-13

Lead Sponsor: German University in Cairo

Target Recruit Count: 70

Registration Number: NCT06458686

Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL

Phase 3

Recruiting

Conditions: ETP-ALL

Interventions: Drug: Cytarabine
Drug: Homoharringtonine
Drug: Vindesine
Drug: venetoclax
Drug: Daunorubicin
Drug: cyclophosphamide
Drug: G-CSF
Drug: Dexamethasone
Drug: L-ASP

First Posted Date: 2024-04-11

Last Posted Date: 2025-02-17

Lead Sponsor: First Affiliated Hospital of Zhejiang University

Target Recruit Count: 81

Registration Number: NCT06361329

Locations: 🇨🇳
The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss

Phase 1

Recruiting

Conditions: Dermatology
Female Pattern Baldness

Interventions: Drug: Topical minoxidil
Drug: Saline spray
Drug: Topical Vitamin D

First Posted Date: 2024-03-27

Last Posted Date: 2024-03-27

Lead Sponsor: Sohag University

Target Recruit Count: 45

Registration Number: NCT06333600

Locations: 🇪🇬
Facult of Medicine, Sohag Uniiversity, Sohag, Egypt

Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata

Not Applicable

Recruiting

Conditions: Alopecia Areata

Interventions: Drug: Lactic Acid
Drug: Saline
Drug: vit D
Drug: Triamcinolone Acetonide

First Posted Date: 2024-03-25

Last Posted Date: 2024-03-25

Lead Sponsor: Zagazig University

Target Recruit Count: 44

Registration Number: NCT06327581

Locations: 🇪🇬
Rana Ehab, Zagazig, Egypt

The Role of Vitamin D in Amelioration of Oral Lichen Planus and Its Effect on Salivary IFN-γ Level

Phase 4

Completed

Conditions: Oral Lichen Planus
Vitamin D Deficiency

Interventions: Drug: vitamin D supplement was given as 60,000 IU weekly in conjunction with systemic prednisone
Drug: Systemic prednisone

First Posted Date: 2024-01-12

Last Posted Date: 2024-01-12

Lead Sponsor: Fayoum University

Target Recruit Count: 40

Registration Number: NCT06204796

Locations: 🇪🇬
Rania Hassan Shalby, Giza, Egypt

A Study to Investigate the Relative Bioavailability and Food Effect of an Oral Capsid Inhibitor Tablet Formulation Compared With Other Oral Tablet Formulations in Male and Female Healthy Participants

Phase 1

Completed

Conditions: HIV Infections

Interventions: Drug: VH4004280 Formulation A
Drug: VH4004280 Formulation B
Drug: VH4004280 Formulation D
Drug: VH4004280 Formulation E
Drug: VH4004280 Formulation C

First Posted Date: 2023-12-13

Last Posted Date: 2024-08-02

Lead Sponsor: ViiV Healthcare

Target Recruit Count: 46

Registration Number: NCT06168318

Locations: 🇬🇧
GSK Investigational Site, Nottingham, United Kingdom

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy